Xoran Technologies, LLC

Xoran Technologies, LLC specializes in advanced imaging solutions with low-dose radiation, providing innovative cone beam CT scanners for veterinary and ENT markets, enhancing diagnostic capabilities and patient care. Xoran Technologies, LLC was founded in 2001 in Ann Arbor, US. The company focuses on providing innovative imaging solutions for the veterinary and ENT medical sectors. The CEO, Miodrag Rakic, has been instrumental in driving the company's vision and growth.

Xoran has successfully raised USD 4. 00 mn in its latest funding round, with Decathlon Capital Partners as the primary investor, contributing to a total raised amount of USD 4. 00 mn. The most recent transaction took place in October 2019, marking the company's commitment to advancing medical imaging technology.

Xoran Technologies specializes in low-dose radiation, cone beam CT scanner systems that cater to both veterinary and ENT (Ear, Nose, and Throat) medical markets. The company offers a suite of advanced imaging products, including the MiniCAT IQ+, xCAT, VetCAT, and vTRON systems. These products are designed for point-of-care use, allowing healthcare providers to perform high-resolution imaging quickly and efficiently. The MiniCAT IQ+, aimed at ENT specialists, provides detailed images of the sinuses, temporal bones, and skull base, while the xCAT serves as a mobile CT scanner for real-time imaging of critical areas such as the brain and skull.

The VetCAT system is specifically designed for veterinary clinics, enabling rapid scanning of pets and facilitating immediate diagnosis and treatment during office visits. Xoran's products are marketed globally, particularly in North America, Europe, and select markets in Asia, where healthcare providers seek to enhance patient access to imaging technologies. Xoran Technologies operates primarily through direct sales of its products to medical and veterinary facilities, establishing long-term partnerships that ensure ongoing support and service provision. The transaction structure is built on a business-to-business (B2B) model, where customers purchase imaging systems alongside complementary services such as maintenance and software solutions.

The company offers various pricing plans tailored to the needs of different client types, from veterinary clinics utilizing VetCAT to ENT specialists employing MiniCAT IQ+. Revenue is generated through the initial sale of the imaging systems, as well as through subscriptions for software services such as XoranConnect, which provides secure, HIPAA-compliant access to imaging data. The specific pricing for each product varies based on the features and services bundled, allowing clients to choose solutions that best fit their operational needs. Xoran Technologies aims to expand its product offerings by developing new imaging systems designed specifically for emerging markets in the medical field, with anticipated launches in 2024.

The company is targeting expansion into additional international markets, including South America and Southeast Asia, by the end of 2025. The recent funding of USD 4. 00 mn will be utilized to support research and development for these upcoming products and to facilitate entry into these new geographic regions.